Results 171 to 180 of about 2,133,508 (317)
A NEW EXAMPLE OF FINITE-DIMENSIONAL REDUCTION OF A DISCRETE CHAIN OF THE TODA CHAIN TYPE
Т Г Казакова +3 more
openalex +1 more source
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
Limitations of Linear Dimensional Reduction Methods in Chronic Obstructive Pulmonary Disease Phenotyping. [PDF]
Takefuji Y.
europepmc +1 more source
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry +16 more
wiley +1 more source
Reply to Takefuji: Limitations of Linear Dimensional Reduction Methods in Chronic Obstructive Pulmonary Disease Phenotyping. [PDF]
Bell AJ, Zinovyev A, Gorban AN.
europepmc +1 more source
Quantifying Interface‐Performance Relationships in Electrochemical CO2 Reduction through Mixed‐Dimensional Assembly of Nanocrystal‐on‐Nanowire Superstructures [PDF]
Hushui Chen +9 more
openalex +1 more source
Objective The aim of this systematic review was to synthesize the economic impact of rheumatoid arthritis (RA) on households, health systems, and society in low‐ and middle‐income countries (LMICs). Methods Electronic databases such as PubMed, Web of Science, and CINAHL were searched using keywords related to RA and cost of illness.
Tadesse Gebrye +6 more
wiley +1 more source
N-Dimensional Reduction Algorithm for Learning from Demonstration Path Planning. [PDF]
Manrique-Cordoba J +2 more
europepmc +1 more source
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen +4 more
wiley +1 more source

